Krieg AM - Search Results

1

Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.

McCluskie MJ, Krieg AM. McCluskie MJ, et al. Among authors: krieg am. Curr Top Microbiol Immunol. 2006;311:155-78. doi: 10.1007/3-540-32636-7_6. Curr Top Microbiol Immunol. 2006. PMID: 17048708 Review.

2

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM. Vollmer J, et al. Among authors: krieg am. Immunology. 2004 Oct;113(2):212-23. doi: 10.1111/j.1365-2567.2004.01962.x. Immunology. 2004. PMID: 15379982 Free PMC article.

3

Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration.

Noll BO, McCluskie MJ, Sniatala T, Lohner A, Yuill S, Krieg AM, Schetter C, Davis HL, Uhlmann E. Noll BO, et al. Among authors: krieg am. Biochem Pharmacol. 2005 Mar 15;69(6):981-91. doi: 10.1016/j.bcp.2004.12.013. Biochem Pharmacol. 2005. PMID: 15748709

4

CpG DNA is an effective oral adjuvant to protein antigens in mice.

McCluskie MJ, Weeratna RD, Krieg AM, Davis HL. McCluskie MJ, et al. Among authors: krieg am. Vaccine. 2000 Nov 22;19(7-8):950-7. doi: 10.1016/s0264-410x(00)00215-2. Vaccine. 2000. PMID: 11115721

5

A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.

Waag DM, McCluskie MJ, Zhang N, Krieg AM. Waag DM, et al. Among authors: krieg am. Infect Immun. 2006 Mar;74(3):1944-8. doi: 10.1128/IAI.74.3.1944-1948.2006. Infect Immun. 2006. PMID: 16495571 Free PMC article.

6

Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.

Chen Y, Lenert P, Weeratna R, McCluskie M, Wu T, Davis HL, Krieg AM. Chen Y, et al. Among authors: krieg am. Gene Ther. 2001 Jul;8(13):1024-32. doi: 10.1038/sj.gt.3301482. Gene Ther. 2001. PMID: 11438837

7

From A to Z on CpG.

Krieg AM. Krieg AM. Trends Immunol. 2002 Feb;23(2):64-5. doi: 10.1016/s1471-4906(01)02150-0. Trends Immunol. 2002. PMID: 11929127 No abstract available.

8

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.

Krieg AM. Krieg AM. Curr Oncol Rep. 2004 Mar;6(2):88-95. doi: 10.1007/s11912-004-0019-0. Curr Oncol Rep. 2004. PMID: 14751085

9

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM. Vollmer J, et al. Among authors: krieg am. Eur J Immunol. 2004 Jan;34(1):251-62. doi: 10.1002/eji.200324032. Eur J Immunol. 2004. PMID: 14971051 Free article.

10

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.

Vollmer J, Krieg AM. Vollmer J, et al. Among authors: krieg am. Adv Drug Deliv Rev. 2009 Mar 28;61(3):195-204. doi: 10.1016/j.addr.2008.12.008. Epub 2009 Jan 13. Adv Drug Deliv Rev. 2009. PMID: 19211030 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters